Search Results - Steven Ballet
- Showing 1 - 14 results of 14
-
1
Peptide hydrogel-drug conjugates for tailored disease treatmentGuidelines to assemble peptide-based hydrogel-drug conjugates, referenced with a selection of relevant publications. by Thibault Cauwenbergh, Steven Ballet, Charlotte Martin
Published in Materials Today Bio (2025-04-01)Get full text
Article -
2
Bifunctional Peptidomimetic G Protein-Biased Mu-Opioid Receptor Agonist and Neuropeptide FF Receptor Antagonist KGFF09 Shows Efficacy in Visceral Pain without Rewarding Effects aft... by Maria Dumitrascuta, Charlotte Martin, Steven Ballet, Mariana Spetea
Published in Molecules (2022-12-01)Get full text
Article -
3
-
4
Harnessing the Anti-Nociceptive Potential of NK2 and NK3 Ligands in the Design of New Multifunctional μ/δ-Opioid Agonist–Neurokinin Antagonist Peptidomimetics by Charlène Gadais, Justyna Piekielna-Ciesielska, Jolien De Neve, Charlotte Martin, Anna Janecka, Steven Ballet
Published in Molecules (2021-09-01)Get full text
Article -
5
-
6
Antinociceptive Efficacy of the µ-Opioid/Nociceptin Peptide-Based Hybrid KGNOP1 in Inflammatory Pain without Rewarding Effects in Mice: An Experimental Assessment and Molecular Doc... by Maria Dumitrascuta, Marcel Bermudez, Olga Trovato, Jolien De Neve, Steven Ballet, Gerhard Wolber, Mariana Spetea
Published in Molecules (2021-05-01)Get full text
Article -
7
A Quantum Chemical Deep-Dive into the π-π Interactions of 3-Methylindole and Its Halogenated Derivatives—Towards an Improved Ligand Design and Tryptophan Stacking by Ruben Van Lommel, Tom Bettens, Thomas M. A. Barlow, Jolien Bertouille, Steven Ballet, Frank De Proft
Published in Pharmaceuticals (2022-07-01)Get full text
Article -
8
Multitarget ligands that comprise opioid/nonopioid pharmacophores for pain management: Current state of the science by Émile Breault, Michael Desgagné, Jolien De Neve, Jérôme Côté, Thomas M.A. Barlow, Steven Ballet, Philippe Sarret
Published in Pharmacological Research (2024-11-01)Get full text
Article -
9
-
10
Developing nanobodies as allosteric molecular chaperones of glucocerebrosidase function by Thomas Dal Maso, Chiara Sinisgalli, Gianluca Zilio, Elisa Franzin, Isabella Tessari, Els Pardon, Jan Steyaert, Steven Ballet, Elisa Greggio, Wim Versées, Nicoletta Plotegher
Published in Nature Communications (2025-05-01)Get full text
Article -
11
Structural basis of μ-opioid receptor targeting by a nanobody antagonist by Jun Yu, Amit Kumar, Xuefeng Zhang, Charlotte Martin, Kevin Van holsbeeck, Pierre Raia, Antoine Koehl, Toon Laeremans, Jan Steyaert, Aashish Manglik, Steven Ballet, Andreas Boland, Miriam Stoeber
Published in Nature Communications (2024-10-01)Get full text
Article -
12
Anti-Human PD-L1 Nanobody for Immuno-PET Imaging: Validation of a Conjugation Strategy for Clinical Translation by Jessica Bridoux, Katrijn Broos, Quentin Lecocq, Pieterjan Debie, Charlotte Martin, Steven Ballet, Geert Raes, Sara Neyt, Christian Vanhove, Karine Breckpot, Nick Devoogdt, Vicky Caveliers, Marleen Keyaerts, Catarina Xavier
Published in Biomolecules (2020-09-01)Get full text
Article -
13
Allosteric nanobodies to study the interactions between SOS1 and RAS by Baptiste Fischer, Tomasz Uchański, Aidana Sheryazdanova, Simon Gonzalez, Alexander N. Volkov, Elke Brosens, Thomas Zögg, Valentina Kalichuk, Steven Ballet, Wim Versées, Anna A. Sablina, Els Pardon, Alexandre Wohlkönig, Jan Steyaert
Published in Nature Communications (2024-07-01)Get full text
Article -
14
Inhibitors of Tax1‐PDZ Interactions Block HTLV‐1 Viral Transmission by Changing EV Composition by Jedidja Puttemans, Yasmine Brammerloo, Karim Blibek, Jeremy Blavier, Thandokuhle Ntombela, Inge Van Molle, Julie Joseph, Julien Olivet, Deeya Saha, Manon Degey, Malik Hamaidia, Pooja Jain, Piel Geraldine, Pascale Zimmermann, Dae‐Kyum Kim, Dominique Baiwir, Makon‐Sébastien Njock, Franck Dequiedt, Kourosh Salehi‐Ashtiani, Steven Ballet, Alexander N. Volkov, Jean‐Claude Twizere, Sibusiso B. Maseko
Published in Journal of Extracellular Vesicles (2025-08-01)Get full text
Article
